Foresight Group Ltd Liability Partnership Takes Position in Veralto Corporation $VLTO

Key Points

• Foresight Group Ltd Liability Partnership has acquired a new stake in Veralto Corporation, purchasing 145,329 shares valued at approximately $14.16 million, making it the 20th largest position in their portfolio.
• Despite recent insider selling by CEO Jennifer Honeycutt, who sold over 10,000 shares, the stock has received favorable ratings from analysts, with Wolfe Research upgrading it to a "strong-buy" rating.
• Veralto reported a quarterly earnings per share of $0.93, surpassing analyst expectations, and has set its FY 2025 EPS guidance between $3.720 and $3.800.

Foresight Group Ltd Liability Partnership acquired a new position in shares of Veralto Corporation (NYSE:VLTO - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 145,329 shares of the company's stock, valued at approximately $14,162,000. Veralto comprises 2.0% of Foresight Group Ltd Liability Partnership's portfolio, making the stock its 20th largest holding. Foresight Group Ltd Liability Partnership owned 0.06% of Veralto at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of VLTO. Nuveen LLC acquired a new stake in Veralto during the 1st quarter worth approximately $172,399,000. Alliancebernstein L.P. lifted its holdings in Veralto by 28.0% during the 1st quarter. Alliancebernstein L.P. now owns 6,235,563 shares of the company's stock worth $607,656,000 after purchasing an additional 1,363,502 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in Veralto by 8.3% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 10,541,438 shares of the company's stock worth $1,027,264,000 after purchasing an additional 811,843 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Veralto by 26.8% during the first quarter. JPMorgan Chase & Co. now owns 3,223,571 shares of the company's stock worth $314,137,000 after buying an additional 682,123 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Veralto by 13.6% during the first quarter. Bank of New York Mellon Corp now owns 4,259,348 shares of the company's stock worth $415,074,000 after buying an additional 509,104 shares in the last quarter. 91.28% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Jennifer Honeycutt sold 10,646 shares of the company's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $106.26, for a total transaction of $1,131,243.96. Following the completion of the transaction, the chief executive officer directly owned 106,219 shares in the company, valued at approximately $11,286,830.94. This represents a 9.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.36% of the company's stock.

Veralto Price Performance

NYSE VLTO traded down $1.02 during trading on Tuesday, hitting $106.78. 259,227 shares of the company's stock were exchanged, compared to its average volume of 1,328,760. The company has a current ratio of 2.32, a quick ratio of 2.06 and a debt-to-equity ratio of 1.00. The company has a market cap of $26.50 billion, a PE ratio of 29.87, a P/E/G ratio of 3.62 and a beta of 0.91. Veralto Corporation has a fifty-two week low of $83.86 and a fifty-two week high of $115.00. The stock's 50 day moving average price is $105.62 and its two-hundred day moving average price is $100.01.

Veralto (NYSE:VLTO - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.04. The business had revenue of $1.37 billion during the quarter, compared to analysts' expectations of $1.34 billion. Veralto had a net margin of 16.65% and a return on equity of 41.45%. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.85 EPS. Veralto has set its FY 2025 guidance at 3.720-3.800 EPS. Q3 2025 guidance at 0.910-0.950 EPS. Research analysts expect that Veralto Corporation will post 3.66 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on VLTO. Royal Bank Of Canada lifted their target price on Veralto from $104.00 to $108.00 and gave the stock a "sector perform" rating in a report on Wednesday, July 30th. Robert W. Baird lifted their price objective on shares of Veralto from $106.00 to $112.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 30th. Wolfe Research upgraded shares of Veralto from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, July 30th. Raymond James Financial initiated coverage on shares of Veralto in a research report on Tuesday, August 26th. They issued a "market perform" rating for the company. Finally, Stifel Nicolaus set a $120.00 price target on shares of Veralto and gave the company a "buy" rating in a research report on Wednesday, July 30th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Veralto presently has an average rating of "Moderate Buy" and a consensus price target of $113.43.

Veralto Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.